Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
Citations Over TimeTop 1% of 2004 papers
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTDipeptidyl Peptidase IV Inhibitors for the Treatment of DiabetesAnn E. WeberView Author Information Merck Research Laboratories, P.O. Box 2000, Rahway, New Jersey 07065 Cite this: J. Med. Chem. 2004, 47, 17, 4135–4141Publication Date (Web):July 20, 2004Publication History Received24 December 2003Published online20 July 2004Published inissue 1 August 2004https://pubs.acs.org/doi/10.1021/jm030628vhttps://doi.org/10.1021/jm030628vreview-articleACS PublicationsCopyright © 2004 American Chemical SocietyRequest reuse permissionsArticle Views3025Altmetric-Citations229LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Carbohydrates,Inhibition,Inhibitors,Peptides and proteins,Rodent models Get e-Alerts
Related Papers
- → Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries(2011)72 cited
- → Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties(1996)26 cited
- → Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties(1996)5 cited
- → Identification of Bile Canalicular Cell Surface Antigen HAM.4 as Dipeptidyl Peptidase IV (DPPIV) and Characterization of Its Role in Hepatic Regeneration After Partial Hepatectomy in Rats(1998)4 cited
- → CD26/dipeptidyl peptidase IV (DPPIV, DAPIV) is a useful molecular marker for thyroid carcinomas(2013)